The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (The QoLiTax-Trial of the Arbeitsgemeinschaft Internistische Onkologie, AIO).
Claudia Pauligk
Research Funding - Sanofi
Wael Hozaeel
Research Funding - Sanofi
Ralf Hofheinz
No relevant relationships to disclose
Axel Hinke
No relevant relationships to disclose
Christiane Windemuth-Kieselbach
No relevant relationships to disclose
Felix Karl Tauchert
Research Funding - Sanofi
Andreas Hübner
No relevant relationships to disclose
Martin Burmester
No relevant relationships to disclose
Michael Koenigsmann
No relevant relationships to disclose
Jörg Wiegand
No relevant relationships to disclose
Jochen Eggert
No relevant relationships to disclose
Manfred Welslau
No relevant relationships to disclose
Rosemarie Kuhl
Employment or Leadership Position - Sanofi-Aventis Deutschland GmbH
Salah-Eddin Al-Batran
Research Funding - Sanofi